Contact: Dan Lamb
+1 440-420-0987
Daniel_Lamb@steris.com
MENTOR, OHIO – November 9, 2022- STERIS announced today it has been named a recipient of the 2022 Pharma Innovation Awards from Pharma Manufacturing for its Purefit™ sterilization bags and covers.
Purefit sterilization bags and covers are designed to protect filling needles, stopper bowls and other items from contamination. STERIS collaborated with DuPont to develop a new grade of uncoated, flexible Tyvek® material optimized for pharmaceutical manufacturing steam sterilization. Purefit sterilization wrapping, constructed from this new grade of Tyvek® material, mitigates the risk of residue and provides quality assurance.
“We developed Purefit sterilization bags and covers to significantly reduce residue risk for pharmaceutical manufacturers when wrapping critical materials for autoclave steam sterilization,” said Elaine Sartain, Vice President, Global Marketing, STERIS Life Sciences Contamination Control Products. “We are delighted to receive a 2022 Pharma Innovation Award and are committed to providing manufacturers with innovative products and services to support contamination control.”
The Pharma Innovation Awards are presented annually to recognize new products and services that support the advancement of technology and equipment in the pharmaceutical manufacturing industry by reducing contamination risk and increasing efficiency.
About STERIS
STERIS’s MISSION IS TO HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science products and services around the globe. For more information, visit www.steris.com.
####
This news release may contain statements concerning certain expectations, forecasts, estimates, product performance or other forward-looking information affecting or relating to the Company or its products that are intended to qualify for the protections afforded "forward- looking statements" under the Private Securities Litigation Reform Act of 1995 and other laws and regulations. Forward-looking statements speak only as to the date of this report, and may be identified by the use of forward-looking terms such as "may," "will," "expects," "believes," "anticipates," "plans," “new,” “advanced,” and “best available,” or the negative of such terms or other variations on such terms or comparable terminology. Many important factors could cause actual results to differ materially from those in this news release including, without limitation, disruption of production or supplies, changes in product use, pending or future claims, technology advances, and changes in government regulations or the application or interpretation thereof. No assurances can be provided as to any product performance or product safety unless all labeling, instructions for use, MSDS and other product literature are strictly followed. Unless legally required, the Company does not undertake to update or revise any forward-looking statements even if events make clear that any projected results, express or implied, will not be realized. Other potential risks and uncertainties that could cause actual results to differ materially from those in this news release include, without limitation, (a) the possibility that market demand will not develop for new technologies, products or application; (b) the possibility that application of or compliance with laws, court rulings, regulations, certifications or other requirements or standards may delay or prevent product introductions, affect the production and marketing of existing products, or otherwise affect product performance; or (c)uses not consistent with product instructions. Product descriptions and performances herein are for illustration only and do not modify labeling, warranties or other technical literature.